GTP BINDING PROTEINS AND ADENYLATE CYCLASE

GTP 结合蛋白和腺苷酸环化酶

基本信息

项目摘要

Cholera toxin, the secretory product of Vibrio cholerae responsible in part for the devastating diarrheal syndrome characteristic of cholera, activates adenylyl cyclase by catalyzing the ADP-ribosylation of Gs-alpha, the stimulatory guanine nucleotide-binding protein of the cyclase system. The toxin-catalyzed reaction is stimulated, in the presence of GTP, by approximately 20 kDa guanine nucleotide-binding proteins, termed ADP-ribosylation factors or ARFs. Rabbit polyclonal antibodies against bovine sARF II reacted with soluble and membrane ARFs but did not react with several other guanine nucleotide-binding proteins. The anti-ARF antibodies reacted with approximately 20 kDa ARF-like proteins in a variety of tissues from several species. The highest levels of immunoreactivity were observed in brain and other neural tissues. In other tissues, an immunoreactive band corresponding to SARF I was present. During rat brain development, when quantified by both immunoreactivity and function, SARF II was lowest at birth, increased somewhat by 10 days, and was maximal at 27-60 days; SARF I was unchanged. The increase of SARF II protein during postnatal development was paralleled by increased ARF 3 mRNA but not by mRNAs for five other ARFs. In the presence of GTP-gamma-S, ARF and toxin formed either an ARF-CTA complex in SDS (SDS) or self-associated ARF in DMPC/cholate, which were separated from monomeric ARF and CTA by gel filtration. Substrate specificities of ARF/toxin complexes were different from those of the monomeric proteins. The ARF 3 gene contains five exons and four introns and spans 18.3 kb. Two ARF 3 mRNAs are synthesized using alternative polyadenylation signals in exon 5. The gene appears to have multiple transcription start sites, no TATA box, no CAAT box and high G/C content in 5' promotor region. The ARF 1 gene is identical to the ARF 3 except that it has only one polyadenylation signal. The organization of the ARF 2 gene is identical to those of ARFs 1 and 3, although the promoter region is somewhat different and thus regulation of ARF 2 gene transcription may differ.
霍乱毒素是霍乱弧菌的分泌物 部分原因是毁灭性的梅毒综合征的特征, 通过催化ADP-核糖基化激活腺苷酸环化酶 Gs-alpha是一种刺激性的鸟嘌呤核苷酸结合蛋白, 环化酶系统 毒素催化的反应被刺激, GTP的存在,通过约20 kDa的鸟嘌呤核苷酸结合 蛋白质,称为ADP核糖基化因子或ARF。 兔多克隆 抗牛sARF II抗体与可溶性和膜性ARF反应 但不与其它几种鸟嘌呤核苷酸结合蛋白反应。 抗ARF抗体与约20 kDa的ARF样蛋白反应 存在于几个物种的多种组织中。 最高层 在脑和其他神经组织中观察到免疫反应性。 换句 组织中出现SARF Ⅰ免疫反应带。 在大鼠脑发育过程中,当通过免疫反应性和 功能,SARF II在出生时最低,10天后有所增加, 在27-60天达到最大值; SARF I无变化。 SARF II的增加 ARF 3 mRNA表达水平的增加, 但其他五种ARF的mRNA却没有。 在GTP-γ-S存在的情况下,ARF和毒素形成了 SDS(SDS)中的ARF-CTA复合物或DMPC/胆酸盐中的自相关ARF, 通过凝胶过滤从单体ARF和CTA中分离。 基板 ARF/毒素复合物的特异性不同于ARF/毒素复合物的特异性。 单体蛋白质 ARF 3基因包含5个外显子和4个内含子, 18.3 KB. 两个ARF 3 mRNA的合成使用交替多聚腺苷酸化 外显子5的信号。该基因似乎有多个转录起始点 5'启动子区无TATA盒和CAAT盒,G/C含量高。 ARF 1基因与ARF 3基因相同,除了它只有一个 多聚腺苷酸化信号。 ARF 2基因的组织结构是相同的 与ARF 1和3的启动子区域相比, 因此ARF 2基因转录的调节可能不同。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

S-C TSAI其他文献

S-C TSAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('S-C TSAI', 18)}}的其他基金

GTP BINDING PROTEINS AND ADENYLYL CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3757603
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3878895
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3779504
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLYL CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    5203492
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GTP BINDING PROTEINS AND ADENYLATE CYCLASE
GTP 结合蛋白和腺苷酸环化酶
  • 批准号:
    3843261
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
  • 批准号:
    10623834
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
  • 批准号:
    2882792
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246530
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246531
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
  • 批准号:
    23K18260
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
  • 批准号:
    10722782
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
  • 批准号:
    23H02688
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
  • 批准号:
    10785159
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
  • 批准号:
    10729566
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Function, composition, and mechanism of RNA splicing factories in cardiomyopathy
RNA剪接工厂在心肌病中的功能、组成和机制
  • 批准号:
    10583011
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了